Heart disease in patients with haemoglobinopathies

  • Dimitrios Farmakis | thalassaemia@cytanet.com.cy Cardiac Clinic for Haemoglobinopathies, First Dept. of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens Medical School, Athens Greece; European University Cyprus Medical School, Nicosia, Cyprus.
  • George Papingiotis Cardiac Clinic for Haemoglobinopathies, First Dept. of Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Abstract

Hereditary hemoglobin disorders, also termed haemoglobinopathies, include mainly beta -thalasszemia and sickle cell disease and represent the most common monogenic disorders in human. Cardiac complications are still a leading cause of mortality and morbidity in patients with haemoglobinopathy, although heart disease due to either severe anaemia or iron overload have dramatically reduced in patient populations receiving modern regular therapy and follow-up. The spectrum of cardiovascular manifestations in haemoglobinopathies is wide and includes ventricular dysfunction, pulmonary hypertension, pericarditis-myocarditis, arrhythmias stroke and thromboembolic events...

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2018-04-19
Info
Issue
Section
14' International Conference on Thalassaemia and Other Haemoglobinopathies & 16' TIF Conference for Patients and Parents
Keywords:
Thalassemia, Hemoglobinopathies.
Statistics
  • Abstract views: 769

  • PDF: 357
  • HTML: 68
How to Cite
Farmakis, D., & Papingiotis, G. (2018). Heart disease in patients with haemoglobinopathies. Thalassemia Reports, 8(1). https://doi.org/10.4081/thal.2018.7480